Point-of-care diagnostics, a major opportunity for change in traditional diagnostic approaches: potential and limitations

References

• Mabey D, Peeling R, Ustianowski A, Perkins M. Diagnostics for the developing world. Nat Rev Microbiol 2004;2(3):231-40
   PubMed Web of Science ®Google Scholar
• Jahn U, Van Aken H. Near-patient testing - point-of-care or point of costs and convenience? Br J Anaesth 2003;90(4):425-7
   Google Scholar
• Chan CPY, Mak WC, Cheung KY, et al. Evidence-based point-of-care diagnostics: current status and emerging technologies. Annu Rev Anal Chem (Palo Alto Calif) 2013;6:191-211
   PubMed Web of Science ®Google Scholar
• Pai NP, Pai M. Point-of-care diagnostics for HIV and tuberculosis: landscape, pipeline, and unmet needs. Discov Med 2012;68:35-45
   Google Scholar
• Lee WG, Kim Y, Chung BG, et al. Nano/Microfluidics for diagnosis of infectious diseases in developing countries. Adv Drug Deliv Rev 2010;62(4-5):449-57
   PubMed Web of Science ®Google Scholar
• Healy DA, Hayes CJ, Leonard P, et al. Biosensor developments: application to prostate-specific antigen detection. Trends Biotechnol 2007;25(3):125-31
   Google Scholar
• Bunde R, Jarvi E, Rosentreter J. Piezoelectric quartz crystal biosensors. Talanta 1998;46(6):1223-36
   Google Scholar
• Byrne B, Stack E, Gilmartin N, O’Kennedy R. Antibody-based sensors: principles, problems and potential for detection of pathogens and associated toxins. Sensors (Basel) 2009;9(6):4407-45
   PubMed Web of Science ®Google Scholar
• Wang C, Sun Z, Ma L, Su M. Simultaneous detection of multiple biomarkers with over three orders of concentration difference using phase change nanoparticles. Anal Chem 2011;83(6):2215-19
   Google Scholar
• Fan X, White IM, Shopova SI, et al. Sensitive optical biosensors for unlabeled targets: a review. Anal Chim Acta 2008;620(2):8-26
   Google Scholar
• Borisov SM, Wolfbeis OS. Optical biosensors. Chem Rev 2008;108(2):423-61
   PubMed Web of Science ®Google Scholar
• Prodromidis MI. Impedimetric immunosensors-A review. Electrochim Acta 2010;55(14):4227-33
   Google Scholar
• Soldatkin OO, Peshkova VM, Saiapina OY, et al. Development of conductometric biosensor array for simultaneous determination of maltose, lactose, sucrose and glucose. Talanta 2013;115:200-7
   Google Scholar
• Posthuma-Trumpie GA, Korf J, van Amerongen A. Lateral flow (immuno) assay: its strengths, weaknesses, opportunities and threats. a literature survey. Anal Bioanal Chem 2009;393(2):569-82
   PubMed Web of Science ®Google Scholar
• Ngom B, Guo Y, Wang X, Bi D. Development and application of lateral flow test strip technology for detection of infectious agents and chemical contaminants: a review. Anal Bioanal Chem 2010;397(3):1113-35
   PubMed Web of Science ®Google Scholar
• World Health Organization – Cardiovascular diseases (CVDs). Available from: www.who.int/mediacentre/factsheets/fs317/en/
   Google Scholar
• Murphy SL, Xu J, Kochanek KD. Deaths: final data for 2010. Natl Vital Stat Rep 2013;61(4):1-117
   PubMedGoogle Scholar
• McDonnell B, Hearty S, Leonard P, O’Kennedy R. Cardiac biomarkers and the case for point-of-care testing. Clin Biochem 2009;42(7-8):549-61
   Google Scholar
• Hansson GK. Inflammation, atherosclerosis, and coronary artery disease. N Engl J Med 2005;352(16):1685-95
   PubMed Web of Science ®Google Scholar
• Suprun EV, Shilovskaya AL, Lisitsa AV, et al. Electrochemical immunosensor based on metal nanoparticles for cardiac myoglobin detection in human blood plasma. Electroanalysis 2011;23(5):1051-7
   Google Scholar
• Boersma E, Mercada N, Poldermans D, et al. Acute myocardial infarction. Lancet 2003;361(9360):847-58
   PubMedGoogle Scholar
• Xu Q, Chan CPY, Cao X, et al. Cardiac multi-marker strategy for effective diagnosis of acute myocardial infarction. Clin Chim Acta 2010;411(21-22):1781-7
   Google Scholar
• Mion MM, Novello E, Altinier S, et al. Analytical and clinical performance of a fully automated cardiac multi-markers strategy based on protein biochip microarray technology. Clin Biochem 2007;40(16-17):1245-51
   Google Scholar
• Peacock F, Morris DL, Anwaruddin S, et al. Acute ischemic heart disease - Meta-analysis of ischemia-modified albumin to rule out acute coronary syndromes in the emergency department. Am Heart J 2006;152(2):253-62
   Google Scholar
• Than M, Cullen L, Reid CM, et al. A 2-h diagnostic protocol to assess patients with chest pain symptoms in the Asia-Pacific region (ASPECT): a prospective observational validation study. Lancet 2011;377(9771):1077-84
   PubMed Web of Science ®Google Scholar
• Stengaard C, Sorensen JT, Ladefoged SA, et al. Quantitative point-of-care troponin T measurement for diagnosis and prognosis in patients with a suspected acute myocardial infarction. Am J Cardiol 2013;112(9):1361-6
   PubMed Web of Science ®Google Scholar
• Lippi G, Mattiuzzi C, Cervellin G. Critical review and meta-analysis on the combination of heart-type fatty acid binding protein (H-FABP) and troponin for early diagnosis of acute myocardial infarction. Clin Biochem 2013;46(1-2):26-30
   PubMed Web of Science ®Google Scholar
• Slot MHEB, Reitsma JB, Rutten FH, et al. Heart-type fatty acid-binding protein in the early diagnosis of acute myocardial infarction: a systematic review and meta-analysis. Heart 2010;96(24):1957-63
   Google Scholar
• Abadie JM, Blassingame CL, Bankson DD. Albumin cobalt binding assay to rule out acute coronary syndrome. Ann Clin Lab Sci 2005;35(1):66-72
   Google Scholar
• Patil SM, Banker MP, Padalkar RK, et al. The clinical assessment of ischaemia modified albumin and troponin I in the early diagnosis of the acute coronary syndrome. J Clin Diagn Res 2013;7(5):804-8
   Google Scholar
• Gaze DC. Biomarkers of cardiac disease (Chapter 6). In: Gaze D, editor. Ischemia heart disease. InTech; Croatia: 2013;p.13. doi; 10.5772/55250
   Google Scholar
• Tomonaga Y, Gutzwiller F, Luescher TF, et al. Diagnostic accuracy of point-of-care testing for acute coronary syndromes, heart failure and thromboembolic events in primary care: a cluster-randomised controlled trial. Bmc Fam Pract 2011;12:12
   PubMed Web of Science ®Google Scholar
• Straface AL, Myers JH, Kirchick HJ, Blick KE. A rapid point-of-care cardiac marker testing strategy facilitates the rapid diagnosis and management of chest pain patients in the emergency department. Am J Clin Pathol 2008;129(5):788-95
   Google Scholar
• Food and Drug Administration - Biosite brand Triage Cardiac Panel. Available from: www.fda.gov/Safety/MedWatch/SafetyInformation/SafetyAlertsforHumanMedicalProducts/ucm150579.htm
   Google Scholar
• Keller T, Zeller T, Peetz D, et al. Sensitive troponin I assay in early diagnosis of acute myocardial infarction. N Engl J Med 2009;361(9):868-77
   PubMed Web of Science ®Google Scholar
• Dekker MS, Mosterd A, van’t Hof AWJ, Hoes AW. Novel biochemical markers in suspected acute coronary syndrome: systematic review and critical appraisal. Heart 2010;96(13):1001-10
   Google Scholar
• Eggers KM, Oldgren J, Nordenskjold A, Lindahl B. Diagnostic value of serial measurement of cardiac markers in patients with chest pain: limited value of adding myoglobin to troponin I for exclusion of myocardial infarction. Am Heart J 2004;148(4):574-81
   PubMed Web of Science ®Google Scholar
• Geersing GJ, Janssen KJM, Oudega R, et al. Excluding venous thromboembolism using point of care D-dimer tests in outpatients: a diagnostic meta-analysis. Br Med J 2009;339:b2990
   PubMed Web of Science ®Google Scholar
• Health Quality Ontario. Point-of-care international normalized ratio (INR) monitoring devices for patients on long-term oral anticoagulation therapy: an evidence-based analysis. Ont Health Technol Assess Ser 2009;9(12):1-114
   Google Scholar
• Ten Cate-Hoek AJ, Prins MH. Management studies using a combination of D-dimer test result and clinical probability to rule out venous thromboembolism: a systematic review. J Thromb Haemost 2005;3(11):2465-70
   Google Scholar
• Bingisser R, Cairns CB, Christ M, et al. Measurement of natriuretic peptides at the point of care in the emergency and ambulatory setting: current status and future perspectives. Am Heart J 2013;166(4):614-21
   Google Scholar
• DahlerEriksen BS, Lassen JF, Petersen PH, et al. Evaluation of a near-patient test for C-reactive protein used in daily routine in primary healthcare by use of difference plots. Clin Chem 1997;43(11):2064-75
   Google Scholar
• Cals JWL, Butler CC, Hopstaken RM, et al. Effect of point of care testing for C reactive protein and training in communication skills on antibiotic use in lower respiratory tract infections: cluster randomised trial. Br Med J 2009;338:b1374
   PubMed Web of Science ®Google Scholar
• Jemal A, Bray F, Center MM, et al. Global cancer statistics. CA Cancer J Clin 2011;61(2):69-90
   PubMed Web of Science ®Google Scholar
• Nelson W, De Marzo A, DeWeese T. The molecular pathogenesis of prostate cancer: Implications for prostate cancer prevention. Urology 2001;57(4A):39-45
   Google Scholar
• American Cancer Society – What are the key statistics about prostate cancer? Available from: www.cancer.org/cancer/prostatecancer/detailedguide/prostate-cancer-key-statistics
   Google Scholar
• Epstein JI. Precursor lesions to prostatic adenocarcinoma. Virchows Arch 2009;454(1):1-16
   Google Scholar
• Sathiakumar N, Delzell E, Morrisey MA, et al. Mortality following bone metastasis and skeletal-related events among men with prostate cancer: a population-based analysis of US Medicare beneficiaries, 1999-2006. Prostate Cancer Prostatic Dis 2011;14(2):177-83
   PubMed Web of Science ®Google Scholar
• Jayasekera J, Onukwugha E, Bikov K, et al. The economic burden of skeletal-related events among elderly men with metastatic prostate cancer. Pharmacoeconomics 2014;32(2):173-91
   PubMed Web of Science ®Google Scholar
• Thompson I, Pauler D, Goodman P, et al. Prevalence of prostate cancer among men with a prostate-specific antigen level <= 4.0 ng per milliliter. N Engl J Med 2004;350(22):2239-46
   PubMed Web of Science ®Google Scholar
• Oh SW, Kim YM, Kim HJ, et al. Point-of-care fluorescence immunoassay for prostate specific antigen. Clin Chim Acta 2009;406(1-2):18-22
   Google Scholar
• Mikolajczyk S, Song Y, Wong J, et al. Are multiple markers the future of prostate cancer diagnostics? Clin Biochem 2004;37(7):519-28
   Google Scholar
• Rhodes D, Sanda M, Otte A, et al. Multiplex biomarker approach for determining risk of prostate-specific antigen-defined recurrence of prostate cancer. J Natl Cancer Inst 2003;95(9):661-8
   PubMedGoogle Scholar
• Gilgunn S, Conroy PJ, Saldova R, et al. Aberrant PSA glycosylation-a sweet predictor of prostate cancer. Nat Rev Urol 2013;10(2):99-107
   PubMed Web of Science ®Google Scholar
• Ilic D, O’Connor D, Green S, Wilt TJ. Screening for prostate cancer: an updated Cochrane systematic review. BJU Int 2011;107(6):882-91
   PubMed Web of Science ®Google Scholar
• Catalona WJ, Partin AW, Sanda MG, et al. A multicenter study of [-2]pro-prostate specific antigen combined with prostate specific antigen and free prostate specific antigen for prostate cancer detection in the 2.0 to 10.0 ng/ml prostate specific antigen range. J Urol 2011;185(5):1650-5
   PubMed Web of Science ®Google Scholar
• Guazzoni G, Nava L, Lazzeri M, et al. Prostate-specific antigen (PSA) Isoform p2PSA significantly improves the prediction of prostate cancer at initial extended prostate biopsies in patients with total PSA between 2.0 and 10 ng/ml: results of a prospective study in a clinical setting. Eur Urol 2011;60(2):214-22
   PubMed Web of Science ®Google Scholar
• Lazzeri M, Haese A, Abrate A, et al. Clinical performance of serum prostate-specific antigen isoform [-2]proPSA (p2PSA) and its derivatives, %p2PSA and the prostate health index (PHI), in men with a family history of prostate cancer: results from a multicentre European study, the PROMEtheuS project. BJU Int 2013;112(3):313-21
   PubMed Web of Science ®Google Scholar
• Hessels D, Gunnewiek JMTK, van Oort I, et al. DD3(PCA3)-based molecular urine analysis for the diagnosis of prostate cancer. Eur Urol 2003;44(1):8-15
   PubMed Web of Science ®Google Scholar
• Sartori DA, Chan DW. Biomarkers in prostate cancer: what’s new? Curr Opin Oncol 2014;26(3):259-64
   PubMed Web of Science ®Google Scholar
• Rajabi H, Ahmad R, Jin C, et al. MUC1-C oncoprotein confers androgen-independent growth of human prostate cancer cells. Prostate 2012;72(15):1659-68
   Google Scholar
• Stenman UH, Leinonen J, Alfthan H, et al. A complex between prostate-specific antigen and alpha-1-antichymotrypsin is the major form of prostate-specific antigen in serum of patients with prostatic-cancer - assay of the complex improves clinical sensitivity for cancer. Cancer Res 1991;51(1):222-6
   PubMed Web of Science ®Google Scholar
• Progensa® PCA3 Assay. Available from: www.gen-probe.com/pdfs/pi/502083-EN-RevB.pdf
   Google Scholar
• Rodon N, Trias I, Verdu M, et al. Diagnostic and predictive value of urine PCA3 gene expression for the clinical management of patients with altered prostatic specific antigen. Actas Urol Esp 2014;38(3):150-5
   Google Scholar
• Vlaeminck-Guillem V, Ruffion A, Andre J, et al. Urinary prostate cancer 3 test: toward the age of reason? Urology 2010;75(2):447-53
   Google Scholar
• UniCel® DxI 800 Immunoassay System. Available from: www.beckmancoulter.com/wsrportal/wsr/diagnostics/clinical-products/immunoassay/unicel-dxl-800/index.htm#2/10//0/25/1/0/asc/2/91500///0/1//0/
   Google Scholar
• Zheng G, Patolsky F, Cui Y, et al. Multiplexed electrical detection of cancer markers with nanowire sensor arrays. Nat Biotechnol 2005;23(10):1294-301
   PubMed Web of Science ®Google Scholar
• Wan Y, Deng W, Su Y, et al. Carbon nanotube-based ultrasensitive multiplexing electrochemical immunosensor for cancer biomarkers. Biosens Bioelectron 2011;30(1):93-9
   PubMed Web of Science ®Google Scholar
• Chin CD, Laksanasopin T, Cheung YK, et al. Microfluidics-based diagnostics of infectious diseases in the developing world. Nat Med 2011;17(8):1015-U138
   PubMed Web of Science ®Google Scholar
• McArthur J, Brew B, Nath A. Neurological complications of HIV infection. Lancet Neurol 2005;4(9):543-55
   PubMed Web of Science ®Google Scholar
• Global Report UNAIDS: Report on the Global AIDS epidemic 2013. Available from: www.unaids.org/en/media/unaids/contentassets/documents/epidemiology/2013/gr2013/unaids_global_report_2013_en.pdf
   Google Scholar
• Anonymous Improving blood safety worldwide. Lancet 2007;370(9585):361-1
   Google Scholar
• Kanekar A. Biomarkers predicting progression of human immunodeficiency virus-related disease. J Clin Med Res 2010;2(2):55-61
   Google Scholar
• Patel P, Mackellar D, Simmons P, et al. Detecting acute human immunodeficiency virus infection using 3 different screening immunoassays and nucleic acid amplification testing for human immunodeficiency virus RNA, 2006-2008. Arch Intern Med 2010;170(1):66-74
   PubMed Web of Science ®Google Scholar
• Cohen MS, Gay CL, Busch MP, Hecht FM. The detection of acute HIV infection. J Infect Dis 2010;202:S270-7
   PubMed Web of Science ®Google Scholar
• Patel P, Bennett B, Sullivan T, et al. Rapid HIV screening: missed opportunities for HIV diagnosis and prevention. J Clin Virol 2012;54(1):42-7
   PubMed Web of Science ®Google Scholar
• Wang S, Xu F, Demirci U. Advances in developing HIV-1 viral load assays for resource-limited settings. Biotechnol Adv 2010;28(6):770-81
   PubMed Web of Science ®Google Scholar
• Whiteaker JR, Zhao L, Zhang HY, et al. Antibody-based enrichment of peptides for mass-spectrometry-based quantification on magnetic beads of serum biomarkers. Anal Biochem 2007;362(1):44-54
   Google Scholar
• World Health Organization Website - HIV/AIDS – summary of new recommendations. Available from: www.who.int/hiv/pub/guidelines/arv2013/intro/rag/en/index2.html
   Google Scholar
• Moon S, Gurkan UA, Blander J, et al. Enumeration of CD4(+) T-cells using a portable microchip count platform in Tanzanian HIV-infected patients. PLoS One 2011;6(7):e21409
   PubMed Web of Science ®Google Scholar
• Glynn MT, Kinahan DJ, Ducrée J. Rapid, low-cost and instrument-free CD4+ cell counting for HIV diagnostics in resource-poor settings. Lab Chip 2014;14(15):2844-51
   Google Scholar
• Branson BM, Stekler JD. Detection of acute HIV infection: we can’t close the window. J Infect Dis 2012;205(4):521-4
   PubMed Web of Science ®Google Scholar
• Manlutac ALM, Giesick JS, McVay PA. Identification of early HIV infections using the fourth generation Abbott ARCHITECT HIV Ag/Ab Combo chemiluminescent microparticle immunoassay (CIA) in San Diego County. J Clin Virol 2013;58:E44-7
   Google Scholar
• Rosenberg NE, Kamanga G, Phiri S, et al. Detection of acute HIV infection: a field evaluation of the determine (R) HIV-1/2 Ag/Ab combo test. J Infect Dis 2012;205(4):528-34
   PubMed Web of Science ®Google Scholar
• Alere DetermineTM HIV-1/2 Ag/Ab Combo. Available from: www.alere.com/us/en/product-details/determine-1-2-ag-ab-combo-us.html
   Google Scholar
• Brauer M, De Villiers JC, Mayaphi SH. Evaluation of the Determine (TM) fourth generation HIV rapid assay. J Virol Methods 2013;189(1):180-3
   Google Scholar
• Kilembe W, Keeling M, Karita E, et al. Failure of a novel, rapid antigen and antibody combination test to detect antigen-positive HIV infection in African Adults with early HIV infection. PLoS One 2012;7(6):e37154
   Google Scholar
• Pavie J, Rachline A, Loze B, et al. Sensitivity of five rapid HIV tests on oral fluid or finger-stick whole blood: a real-time comparison in a healthcare setting. PLoS One 2010;5(7):e11581
   Google Scholar
• Conway DP, Holt M, McNulty A, et al. Multi-centre evaluation of the determine HIV combo assay when used for point of care testing in a high risk clinic-based population. PLoS one 2014;9(4):e94062
   Google Scholar
• Byrne H, Conroy PJ, Whisstock JC, O’Kennedy RJ. A tale of two specificities: bispecific antibodies for therapeutic and diagnostic applications. Trends Biotechnol 2013;31(11):621-32
   PubMed Web of Science ®Google Scholar
• Dormans J, Burger M, Aguilar D, et al. Correlation of virulence, lung pathology, bacterial load and delayed type hypersensitivity responses after infection with different Mycobacterium tuberculosis genotypes in a BALB/c mouse model. Clin Exp Immunol 2004;137(3):460-8
   PubMed Web of Science ®Google Scholar
• Lin P, Pawar S, Myers A, et al. Early events in Mycobacterium tuberculosis infection in cynomolgus macaques. Infect Immun 2006;74(7):3790-803
   Google Scholar
• Wallis RS, Pai M, Menzies D, et al. Tuberculosis 4 Biomarkers and diagnostics for tuberculosis: progress, needs, and translation into practice. Lancet 2010;375(9729):1920-37
   PubMed Web of Science ®Google Scholar
• WHO. Diagnostics evaluation series 2 -laboratory-based evaluation of 19 commercially available rapid diagnostic tests for tuberculosis. WHO; Geneva, Switzerland: 2008
   Google Scholar
• Ferrara G, Losi M, D’Amico R, et al. Use in routine clinical practice of two commercial blood tests for diagnosis of infection with Mycobacterium tuberculosis: a prospective study. Lancet 2006;367(9519):1328-34
   PubMed Web of Science ®Google Scholar
• Luetkemeyer AF, Charlebois ED, Flores LL, et al. Comparison of an interferon-gamma release assay with tuberculin skin testing in HIV-infected individuals. Am J Respir Crit Care Med 2007;175(7):737-42
   PubMed Web of Science ®Google Scholar
• Kobashi Y, Mouri K, Yagi S, et al. Usefulness of the QuantiFERON TB-2G test for the differential diagnosis of pulmonary tuberculosis. Intern Med 2008;47(4):237-43
   Google Scholar
• Ruhwald M, Bjerregaard-Andersen M, Rabna P, et al. IP-10, MCP-1, MCP-2, MCP-3, and IL-1RA hold promise as biomarkers for infection with M. tuberculosis in a whole blood based T-cell assay. BMC Res Notes 2009;2:19-19
   PubMedGoogle Scholar
• Ruhwald M, Bodmer T, Maier C, et al. Evaluating the potential of IP-10 and MCP-2 as biomarkers for the diagnosis of tuberculosis. Eur Respir J 2008;32(6):1607-15
   PubMed Web of Science ®Google Scholar
• Frahm M, Goswami ND, Owzar K, et al. Discriminating between latent and active tuberculosis with multiple biomarker responses. Tuberculosis (Edinb) 2011;91(3):250-6
   Google Scholar
• Whittaker E, Gordon A, Kampmann B. Is IP-10 a better biomarker for active and latent tuberculosis in children than IFN gamma? PLoS One 2008;3(12):e3901
   Google Scholar
• Bielekova B, Komori M, Xu Q, et al. Cerebrospinal fluid IL-12p40, CXCL13 and IL-8 as a combinatorial biomarker of active intrathecal inflammation. PLoS One 2012;7(11):e48370
   PubMed Web of Science ®Google Scholar
• Kim YW, Bae SM, Lim H, et al. Development of multiplexed bead-based immunoassays for the detection of early stage ovarian cancer using a combination of serum biomarkers. PLoS One 2012;7(9):e44960
   Google Scholar
• Liu C, Liu A, Halabi S. A min-max combination of biomarkers to improve diagnostic accuracy. Stat Med 2011;30(16):2005-14
   Google Scholar
• Glannelli G, Fransvea E, Trerotoli P, et al. Clinical validation of combined serological biomarkers for improved hepatocellular carcinoma diagnosis in 961 patients. Clin Chim Acta 2007;383(1-2):147-52
   Google Scholar
• Makawita S, Dimitromanolakis A, Soosaipillai A, et al. Validation of four candidate pancreatic cancer serological biomarkers that improve the performance of CA19.9. BMC Cancer 2013;13:404
   PubMed Web of Science ®Google Scholar
• Wang F, Hou H, Xu L, et al. Mycobacterium tuberculosis-specific TNF-alpha is a potential biomarker for the rapid diagnosis of active tuberculosis disease in Chinese population. PLoS One 2013;8(11):e79431
   Google Scholar
• Haddow LJ, Dibben O, Moosa MS, et al. Circulating inflammatory biomarkers can predict and characterize tuberculosis-associated immune reconstitution inflammatory syndrome. AIDS 2011;25(9):1163-74
   PubMed Web of Science ®Google Scholar
• Shekhawat SD, Jain RK, Gaherwar HM, et al. Heat shock proteins: possible biomarkers in pulmonary and extrapulmonary tuberculosis. Hum Immunol 2014;75(2):151-8
   Google Scholar
• Breslauer DN, Maamari RN, Switz NA, et al. Mobile phone based clinical microscopy for global health applications. PLoS One 2009;4(7):e6320
   PubMed Web of Science ®Google Scholar
• Perkins MD, Cunningham J. Facing the crisis: improving the diagnosis of tuberculosis in the HIV era. J Infect Dis 2007;196:S15-27
   PubMed Web of Science ®Google Scholar
• Lane ND, Miluzzo E, Lu H, et al. A survey of mobile phone sensing. IEEE Commun Mag 2010;48(9):140-50
   Web of Science ®Google Scholar
• Linder E, Grote A, Varjo S, et al. On-chip imaging of schistosoma haematobium eggs in urine for diagnosis by computer vision. Plos Negl Trop Dis 2013;7(12):e2547
   Google Scholar
• Tseng D, Mudanyali O, Oztoprak C, et al. Lensfree microscopy on a cellphone. Lab Chip 2010;10(14):1787-92
   PubMed Web of Science ®Google Scholar
• Lillehoj PB, Huang M, Truong N, Ho C. Rapid electrochemical detection on a mobile phone. Lab Chip 2013;13(15):2950-5
   Google Scholar
• Veigas B, Jacob JM, Costa MN, et al. Gold on paper-paper platform for Au-nanoprobe TB detection. Lab Chip 2012;12(22):4802-8
   PubMed Web of Science ®Google Scholar
• Khandoker AH, Black J Palaniswami M. Smartphone-based low cost oximeter photoplethysmography. 2010 International Conference on Electrical and Computer Engineering (ICECE); 18 - 20 Dec 2010; Dhaka,Bangladesh p. 634-7
   Google Scholar
• Karlen W, Dumont G, Petersen C, et al. Human-centered phone oximeter interface design for the operating room pulse oximeter interfaced to a mobile device for anesthesia monitoring in the developing world. HEALTHINF 2011 - Proceedings of the International Conference on Health Informatics; 26 - 29 January 2011; Rome, Italy
   Google Scholar
• Shinar J, Shinar R. Organic light-emitting devices (OLEDs) and OLED-based chemical and biological sensors: an overview. J Phys DAppl Phys 2008;41(13):133001
   Google Scholar
• Mancuso M, Jiang L, Cesarman E, Erickson D. Multiplexed colorimetric detection of Kaposi’s sarcoma associated herpesvirus and Bartonella DNA using gold and silver nanoparticles. Nanoscale 2013;5(4):1678-86
   Google Scholar
• Soo P, Horng Y, Chang K, et al. A simple gold nanoparticle probes assay for identification of Mycobacterium tuberculosis and Mycobacterium tuberculosis complex from clinical specimens. Mol Cell Probes 2009;23(5):240-6
   PubMed Web of Science ®Google Scholar
• Li C, Vandenberg K, Prabhulkar S, et al. Paper based point-of-care testing disc for multiplex whole cell bacteria analysis. Biosens Bioelectron 2011;26(11):4342-8
   PubMed Web of Science ®Google Scholar
• Fu E, Liang T, Houghtaling J, et al. Enhanced sensitivity of lateral flow tests using a two-dimensional paper network format. Anal Chem 2011;83(20):7941-6
   PubMed Web of Science ®Google Scholar
• Theron G, Zijenah L, Chanda D, et al. Feasibility, accuracy, and clinical effect of point-of-care Xpert MTB/RIF testing for tuberculosis in primary-care settings in Africa: a multicentre, randomised, controlled trial. Lancet 2014;383(9915):424-35
   PubMed Web of Science ®Google Scholar
• Glynn M, Kirby D, Chung D, et al. Centrifugo-magnetophoretic purification of CD4+ cells from whole blood toward future HIVAIDS point-of-care applications. J Lab Autom 2013;19(3):285-96
   Google Scholar
• Shafiee H, Jahangir M, Inci F, et al. Acute on-chip HIV detection through label-free electrical sensing of viral nano-lysate. Small 2013;9(15):2553-63
   PubMed Web of Science ®Google Scholar
• Chen Z, Abrams WR, Geva E, et al. Development of a generic microfluidic device for simultaneous detection of antibodies and nucleic acids in oral fluids. Biomed Res Int 2013;2013:543294
   Google Scholar
• Shekalaghe S, Cancino M, Mavere C, et al. Clinical performance of an automated reader in interpreting malaria rapid diagnostic tests in Tanzania. Malar J 2013;12:141
   Google Scholar
• Bock JL, Singer AJ, Thode HC Jr. Comparison of emergency department patient classification by point-of-care and central laboratory methods for cardiac troponin I. Am J Clin Pathol 2008;130(1):132-5
   Google Scholar
• Venge P, Ohberg C, Flodin M, Lindahl B. Early and late outcome prediction of death in the emergency room setting by point-of-care and laboratory assays of cardiac troponin I. Am Heart J 2010;160(5):835-41
   Google Scholar
• Capoluongo E, Zambon CF, Basso D, et al. PCA3 score of 20 could improve prostate cancer detection: results obtained on 734 Italian individuals. Clin Chim Acta 2014;429:46-50
   Google Scholar
• Pepe P, Fraggetta F, Galia A, et al. PCA3 score and prostate cancer diagnosis at repeated saturation biopsy. which cut-off: 20 or 35? Int Braz J Urol 2012;38(4):489-95
   Google Scholar
• Ochiai A, Okihara K, Kamoi K, et al. Clinical utility of the prostate cancer gene 3 (PCA3) urine assay in Japanese men undergoing prostate biopsy. BJU Int 2013;111(6):928-33
   PubMed Web of Science ®Google Scholar
• Adam A, Engelbrecht MJ, Bornman MS, et al. The role of the PCA3 assay in predicting prostate biopsy outcome in a South African setting. BJU Int 2011;108(11):1728-33
   PubMed Web of Science ®Google Scholar
• Fossati N, Lazzeri M, Haese A, et al. Clinical performance of serum isoform [-2]proPSA (p2PSA) and its derivatives, namely %p2PSA and PHI (Prostate Health Index) in men younger than 60 years of age: results from a multicentre European study. BJU Int 2014; doi; 10.1111/bju.12718. [Epub ahead of print]
   Google Scholar
• Guazzoni G, Lazzeri M, Nava L, et al. Preoperative prostate-specific antigen isoform p2PSA and its derivatives, %p2PSA and prostate health index, predict pathologic outcomes in patients undergoing radical prostatectomy for prostate cancer. Eur Urol 2012;61(3):455-66
   PubMed Web of Science ®Google Scholar
• Lazzeri M, Haese A, de la Taille A, et al. Serum Isoform [-2]proPSA derivatives significantly improve prediction of prostate cancer at initial biopsy in a total PSA range of 2-10 ng/ml: a multicentric European study. Eur Urol 2013;63(6):986-94
   PubMed Web of Science ®Google Scholar
• Agnihotri S, Mittal RD, Ahmad S, Mandhani A. Free to total serum prostate specific antigen ratio in symptomatic men does not help in differentiating benign from malignant disease of the prostate. Indian J Urol 2014;30(1):28-32
   Google Scholar
• Lee R, Localio AR, Armstrong K, Free PSA Study Grp. A meta-analysis of the performance characteristics of the free prostate-specific antigen test. Urology 2006;67(4):762-8
   PubMed Web of Science ®Google Scholar
• Yoneyama T, Ohyama C, Hatakeyama S, et al. Measurement of aberrant glycosylation of prostate specific antigen can improve specificity in early detection of prostate cancer. Biochem Biophys Res Commun 2014;448(4):390-6
   PubMed Web of Science ®Google Scholar
• Zhang Z, Yang J, Zhang C, et al. The value of magnetic resonance imaging in the detection of prostate cancer in patients with previous negative biopsies and elevated prostate-specific antigen levels: a meta-analysis. Acad Radiol 2014;21(5):578-89
   Google Scholar
• Herbert S, Edwards S, Carrick G, et al. Evaluation of PIMA point-of-care CD4 testing in a large UK HIV service. Sex Transm Infect 2012;88(6):413-17
   PubMed Web of Science ®Google Scholar
• Jani IV, Sitoe NE, Alfai ER, et al. Effect of point-of-care CD4 cell count tests on retention of patients and rates of antiretroviral therapy initiation in primary health clinics: an observational cohort study. Lancet 2011;378(9802):1572-9
   PubMed Web of Science ®Google Scholar
• Galiwango RM, Lubyayi L, Musoke R, et al. Field evaluation of PIMA point-of-care CD4 testing in Rakai, Uganda. PLoS One 2014;9(3):e88928
   Google Scholar
• Mtapuri-Zinyowera S, Chideme M, Mangwanya D. Evaluation of the PIMA point-of-care CD4 analyzer in VCT clinics in Zimbabwe. J Acquir Immune Defic Syndr 2010;55(1):1-7
   PubMed Web of Science ®Google Scholar
• Bergman J, Gratrix J, Plitt S, et al. Feasibility and field performance of a simultaneous syphilis and HIV point-of-care test based screening strategy in at risk populations in Edmonton, Canada. AIDS Res Treat 2013;2013:819593-3
   PubMedGoogle Scholar
• INSTI HIV-1/HIV-2 Antibody Test. Available from: www.biolytical.com/insti_doc/CEInsert.pdf
   Google Scholar
• Lee BE, Plitt S, Fenton J, et al. Rapid HIV tests in acute care settings in an area of low HIV prevalence in Canada. J Virol Methods 2011;172(1-2):66-71
   Google Scholar
• Parpia ZA, Elghanian R, Nabatiyan A, et al. p24 antigen rapid test for diagnosis of acute pediatric HIV infection. J Acquir Immune Defic Syndr 2010;55(4):413-19
   Google Scholar
• Kfutwah A, Lemée V, Ngono HV, et al. Field evaluation of the Abbott ARCHITECT HIV Ag/Ab Combo immunoassay. J Clin Virol 2013;58(Suppl 1):e70-5
   Google Scholar
• Tao CM, Cho Y, Ng KP, et al. Validation of the Elecsys® HIV combi PT assay for screening and reliable early detection of HIV-1 infection in Asia. J Clin Virol 2013;58(1):221-6
   Google Scholar
• Mercier-Delarue S, Vray M, Plantier JC, et al. Higher specificity of nucleic acid sequence-based amplification isothermal technology than of real-time PCR for quantification of HIV-1 RNA on dried blood spots. J Clin Microbiol 2014;52(1):52-6
   PubMed Web of Science ®Google Scholar
• Chang K, Lu W, Wang J, et al. Rapid and effective diagnosis of tuberculosis and rifampicin resistance with Xpert MTB/RIF assay: a meta-analysis. J Infect 2012;64(6):580-8
   PubMed Web of Science ®Google Scholar
• Menzies D, Pai M, Comstock G. Meta-analysis: new tests for the diagnosis of latent tuberculosis infection: areas of uncertainty and recommendations for research. Ann Intern Med 2007;146(5):340-54
   PubMed Web of Science ®Google Scholar
• Sollai S, Galli L, de Martino M, Chiappini E. Systematic review and meta-analysis on the utility of Interferon-gamma release assays for the diagnosis of Mycobacterium tuberculosis infection in children: a 2013 update. BMC Infect Dis 2014;14:S6
   PubMed Web of Science ®Google Scholar
• Steingart KR, Flores LL, Dendukuri N, et al. Commercial serological tests for the diagnosis of active pulmonary and extrapulmonary tuberculosis: an updated systematic review and meta-analysis. Plos Med 2011;8(8):e1001062
   PubMed Web of Science ®Google Scholar
• Anderson BL, Welch RJ, Litwin CM. Assessment of three commercially available serologic assays for detection of antibodies to mycobacterium tuberculosis and identification of active tuberculosis. Clin Vaccine Immunol 2008;15(11):1644-9
   Google Scholar
• Blick KE. Economic and Operational benefits of a rapid, Point-of-care cTnI-only protocol for triaging patients with chest pain in the emergency department. Available from: www.abbottpointofcare.com/EducationCenter/∼/media/Files/PDFS/Home/iLearn-Center/Case-Studies/030753_Oklahoma_Univ_Troponin_Paper.ashx
   Google Scholar